×

Concerned about your own or
someone else’s drug use?

The National Alcohol and Other Drug Hotline

For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information

Counselling online

An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information

Cracks in the ice

An online toolkit providing evidence-based and up-to-date information and resources about crystal methamphetamine (ice) for the Australian community. Click here for more information

Generate

New evidence
based knowledge

NCCRED Clinical Research Funding

Allocated and available funding

Jump down to

Funding recipients

Seed Funding Recipients: Round 3

A key objective of NCCRED is to provide seed-funding to establish new clinical trials and clinical research, in order to build capacity for clinical research in the Alcohol and Other Drug (AOD) sector.  Seed funding was granted through a formal application process with the level of funding determined by the NCCRED Board.

Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.

Amount Awarded: $95,481.00

Rapid translation of forensic data from police drug seizures into clinical alerts to improve public health

Principal Investigator: Dr Monica Barratt, Royal Melbourne Institute of Technology.

Amount Awarded: $95,481.00

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

Amount awarded: $94,369.00

Determining the feasibility and efficacy of Goal Management Training for improving treatment retention and outcomes during residential treatment for methamphetamine dependence

Principal Investigator: Prof Antonio Verdejo-Garcia, Monash University

Amount awarded: $94,369.00

Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study

Principal Investigator: Prof Andrew Dawson, University of Sydney.

Amount awarded: $95,000.00

Detection of fever via wearable thermometers: An early intervention strategy to reduce the risk of drug-related toxicity at music festivals, a feasibility and acceptability study

Principal Investigator: Prof Andrew Dawson, University of Sydney.

Amount awarded: $95,000.00

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $61,342.00

BeSMART: feasibility and preliminary efficacy of an intervention for family members impacted by methamphetamine

Principal Investigator: A/Prof Peter Kelly, University of Wollongong

Amount awarded: $61,342.00

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.

Principal Investigator: A/Prof Suzanne Nielson, Monash University

Amount awarded: $98,774.00

Understanding emerging opioid-related harms through improved surveillance, drug checking and information sharing systems.

Principal Investigator: A/Prof Suzanne Nielson, Monash University

Amount awarded: $98,774.00

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health

Amount awarded: $97,844.25

An open label pilot study of intranasal oxytocin for methamphetamine withdrawal in women

Principal Investigator: Dr Shalini Arunogiri, Turning Point, Eastern Health

Amount awarded: $97,844.25

Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Principal Investigator: Dr Amy Peacock, University of New South Wales

Amount awarded: $96,120.00

Risk communication for people who use MDMA/‘ecstasy’ and related drugs: establishing guidance on consumer preferences and behavioural responses to drug alerts

Principal Investigator: Dr Amy Peacock, University of New South Wales

Amount awarded: $96,120.00

Seed Funding Recipients: Round 2

An open-label pilot study of sub-anaesthetic ketamine for methamphetamine abuse in young people.

Principal Investigator: Dr G Bedi, Orygen: The National Centre of Excellence in Youth Mental Health (Vic).

Amount awarded: $99,703.53.

An open-label pilot study of sub-anaesthetic ketamine for methamphetamine abuse in young people.

Principal Investigator: Dr G Bedi, Orygen: The National Centre of Excellence in Youth Mental Health (Vic).

Amount awarded: $99,703.53.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.

Principal Investigator: A/Prof P Kelly, University of Wollongong (NSW).

Amount awarded: $77,489.00.

Methamphetamine and mutual support: a mixed methods exploration of SMART recovery participants’ characteristics and opportunities for enhanced referral pathways.

Principal Investigator: A/Prof P Kelly, University of Wollongong (NSW).

Amount awarded: $77,489.00.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.

Principal Investigator: A/Prof V. Manning, Monash University (Vic).

Amount awarded: $97,595.30.

A pilot randomised controlled trial (RCT) of personalised approach bias modification for methamphetamine use disorder.

Principal Investigator: A/Prof V. Manning, Monash University (Vic).

Amount awarded: $97,595.30.

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.

Principal Investigator: Dr R.Sutherland, The University of New South Wales (NSW).

Amount awarded: $38,795.00.

Feasibility, consumer acceptability and behavioural outcomes associated with take-home fentanyl test strips.

Principal Investigator: Dr R.Sutherland, The University of New South Wales (NSW).

Amount awarded: $38,795.00.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.

Principal Investigator: A/Prof J. Ward, South Australian Health and Medical Research Institute (SA).

Amount awarded: $68,400.00.

An acceptability and feasibility study of the We Can Do This online therapeutic program in primary care and residential rehabilitation settings.

Principal Investigator: A/Prof J. Ward, South Australian Health and Medical Research Institute (SA).

Amount awarded: $68,400.00.

Seed Funding Recipients: Round 1

 

Round 1 Seed Funding and Capacity Building Grants Presentations

Recipients of Round 1 Seed Funding and Capacity Building Grants presented on their research at the 2019 NCCRED Symposium. You can view the Symposium program and watch the presentations on our website here

Emerging Drug Network of Australia (EDNA)

Principal Investigator: Dr J.Soderstrom, Royal Perth Hospital (WA)

Amount awarded: $100,000.00

Emerging Drug Network of Australia (EDNA)

Principal Investigator: Dr J.Soderstrom, Royal Perth Hospital (WA)

Amount awarded: $100,000.00

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views

Principal Investigator: Dr B.Larance, University of Wollongong (NSW)

Amount awarded: $66,190.00.

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data and consumer and clinician views

Principal Investigator: Dr B.Larance, University of Wollongong (NSW)

Amount awarded: $66,190.00.

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Principal Investigator: Dr C. Rodgers, St Vincent’s Hospital Sydney (NSW)

Amount awarded: $29,947.50

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Principal Investigator: Dr C. Rodgers, St Vincent’s Hospital Sydney (NSW)

Amount awarded: $29,947.50

Capacity Building grants

NCCRED awarded one round of Capacity building grants to existing investigator-initiated methamphetamine treatment research to expand clinical research capacity and national reach.

Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project

Principal Investigator: Prof N. Lintzeris, South Eastern Sydney Local Health District (NSW) 

Amount awarded: $104,000.00 

Developing a clinical data laboratory for methamphetamine use in NSW: The MAData project

Principal Investigator: Prof N. Lintzeris, South Eastern Sydney Local Health District (NSW) 

Amount awarded: $104,000.00 

The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

Principal Investigator: Prof P.Haber, Royal Prince Alfred Hospital (NSW) 

Amount awarded: $100,000.00 

The LiMA@RPAH study: a randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence

Principal Investigator: Prof P.Haber, Royal Prince Alfred Hospital (NSW) 

Amount awarded: $100,000.00 

South Australian drug early warning system – Emergency Department admission blood psychoactive testing

Principal Investigator: Dr P.Stockham, Forensic Science SA (SA) 

Amount awarded: $100,000.00    

South Australian drug early warning system – Emergency Department admission blood psychoactive testing

Principal Investigator: Dr P.Stockham, Forensic Science SA (SA) 

Amount awarded: $100,000.00    

National Centre for Clinical
Research on Emerging Drugs

We would like to acknowledge the traditional owners of this country
and pay our respects to Elders past, present and emerging.

© Copyright 2020